The Use of Proton MR in Cancer Pathology
暂无分享,去创建一个
Carolyn E. Mountford | W. Mackinnon | C. Mountford | P. Russell | Peter Russell | Cynthia L. Lean | Wanda B. Mackinnon | C. Lean
[1] N. Hunt,et al. Development of the “activated” high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle , 1990, Magnetic resonance in medicine.
[2] W. Mackinnon,et al. Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts , 1988, International journal of cancer.
[3] O. Jardetzky,et al. Determination of metabolite and nucleotide concentrations in proliferating lymphocytes by 1H-NMR of acid extracts. , 1990, Biochimica et biophysica acta.
[4] B. Sordat,et al. Establishment of a cell line (Co-115) from a human colon carcinoma transplanted into nude mice. , 1976, Cancer research.
[5] K. Bock,et al. The conformations of oligosaccharides related to the ABH and Lewis human blood group determinants , 1980 .
[6] S. Pilotti,et al. High‐resolution 1H NMR spectroscopy in the diagnosis of breast cancer , 1988, Magnetic resonance in medicine.
[7] P. Meakin,et al. Homonuclear decoupling and peak elimination in Fourier transform nuclear magnetic resonance , 1973 .
[8] C. Tropé,et al. Age and prognosis in stage Ib squamous cell carcinoma of the uterine cervix. , 1983, Gynecologic oncology.
[9] M. Brattain,et al. Characterization of human colon carcinoma cell lines isolated from a single primary tumour. , 1983, British Journal of Cancer.
[10] I. Smith,et al. Biological and NMR markers for cancer. , 1991, Pharmacology & therapeutics.
[11] W F Taylor,et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. , 1984, Journal of neurosurgery.
[12] W. Mackinnon,et al. Uterine cervical punch biopsy specimens can be analyzed by 1h mrs , 1990, Magnetic resonance in medicine.
[13] B. Armstrong,et al. INCREASING MORTALITY FROM CANCER OF THE CERVIX IN YOUNG AUSTRALIAN WOMEN , 1981, The Medical journal of Australia.
[14] B. Rose,et al. Papillomavirus and cervical cancer: A clinical and laboratory study , 1988, Journal of medical virology.
[15] T R Brown,et al. Practical applications of chemical shift imaging , 1992, NMR in biomedicine.
[16] A. Leibovitz,et al. Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.
[17] V. R. McCready,et al. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. , 1991, British Journal of Cancer.
[18] J. Frahm,et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.
[19] W. Mackinnon,et al. Fucose in 1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells , 1991, Magnetic resonance in medicine.
[20] C. Paraskeva,et al. Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. , 1990, Cancer research.
[21] C. Mountford,et al. Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model. , 1988, Trends in biochemical sciences.
[22] G. Trugnan,et al. The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate. , 1985, The Journal of biological chemistry.
[23] R M Fox,et al. Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy. , 1982, Cancer research.
[24] G. Sheline. Radiation therapy of brain tumors , 1977, Cancer.
[25] C. Mountford,et al. Identification of 1-O-Alkyl-2,3-diacyl-sn-glycerol in plasma membranes of cancer cells , 1992 .
[26] Kjørstad Ke. Carcinoma of the cervix in the young patient. , 1977 .
[27] C. Hardy,et al. A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? , 1987, Medical physics.
[28] W. T. Dixon. Simple proton spectroscopic imaging. , 1984, Radiology.
[29] R. Whitehead,et al. A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. , 1987, Cancer research.
[30] A. Gazdar,et al. CHARACTERISTICS OF COLORECTAL CARCINOMA CELL LINES paraffin embedded sections of xenografts , 2006 .
[31] D. Leibfritz,et al. Pre-operative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla--first results. , 1989, Magnetic resonance imaging.
[32] D. Sheer,et al. The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients , 1984, International journal of cancer.
[33] V. Bertone,et al. Histochemical probes for the detection of hypoxic tumour cells. , 1990, Anticancer research.
[34] M. Sobrinho-Simões,et al. The fine structure of follicular thyroid adenomas. , 1982, American journal of clinical pathology.
[35] R. Buist,et al. Identification of lactate, threonine and alanine in rat thymus and tumorigenic lymphoid cells using 1H 2‐D COSY NMR spectroscopy , 1992, NMR in biomedicine.
[36] W. Mackinnon,et al. Tumour evolution in rats monitored by changes to serum and lipoproteins. , 1991, Invasion & metastasis.
[37] P E Wright,et al. Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. , 1986, The Journal of biological chemistry.
[38] J. Saunders,et al. A simple procedure for obtaining high‐quality nmr spectra of semiquantitative value from small tissue specimens: cervical biopsies. , 1992, Magnetic resonance in medicine.
[39] R. Damadian. Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.
[40] V. Viti,et al. RNA-lipid complexes released from the plasma membrane of human colon carcinoma cells. , 1988, Cancer letters.
[41] C. Mountford,et al. Identification of triglyceride in malignant cells , 1991 .
[42] R. Welsh,et al. Interferon‐induced increase in neuraminidase‐releasable sialic acid and glycosphingolipid metabolism in mouse lymphoma and l1210 leukemic cell lines: Correlation with susceptibility to natural killer cell‐mediated lysis , 1983, International journal of cancer.
[43] S. Hakomori,et al. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.
[44] L. Hall,et al. Chemical-shift-resolved tomography using frequency-selective excitation and suppression of specific resonances , 1984 .
[45] B. Armstrong,et al. Cervical cancer mortality trends in Australia — an update , 1987, The Medical journal of Australia.
[46] S. Finerty,et al. Immortalization of a human colorectal adenoma cell line by continuous in vitro passage: Possible involvement of chromosome 1 in tumour progression , 2006, International journal of cancer.
[47] F. Patel,et al. Sucralfate enema in ulcerative rectosigmoid lesions , 1990, Diseases of the colon and rectum.
[48] G. King,et al. An NMR investigation of the changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes. , 1992, Biochemistry.
[49] C. Mountford,et al. Application of a T2,‐filtered COSY experiment to identify the origin of slowly relaxing species in normal and malignant tissue , 1988, Magnetic resonance in medicine.
[50] C. Bodian,et al. Lobular neoplasia (so‐called lobular carcinoma in situ) of the breast , 1978, Cancer.
[51] R. Whitehead,et al. A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. , 1985, Journal of the National Cancer Institute.
[52] I. Fidler,et al. Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.
[53] G Friedmann,et al. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.
[54] M. Bloom,et al. Complete proton magnetic resonance in whole cells , 1986 .
[55] W. Sewchand,et al. The Influence of Patientsʼ Age and Tumor Grade on the Prognosis of Carcinoma of the Cervix , 1983 .
[56] T. Brown,et al. Free magnesium levels in normal human brain and brain tumors: 31P chemical-shift imaging measurements at 1.5 T. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[57] K. Maruyama,et al. Massive accumulation of neutral lipids in cells conditionally transformed by an activated H-ras oncogene. , 1991, Oncogene.
[58] David G. Gadian,et al. Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.
[59] R. Gelber,et al. Axillary node micrometastases and breast cancer , 1991, The Lancet.
[60] M. Coppleson,et al. Puzzling changes in cervical cancer in young women , 1987, The Medical journal of Australia.
[61] M. Duggan,et al. Invasive squamous cell carcinoma of the cervix in women less than 35 years old: Recurrent versus nonrecurrent disease , 1988, American journal of obstetrics and gynecology.
[62] W. Bodmer,et al. Growth factor requirements of human colorectal tumour cells: relations to cellular differentiation. , 1991, European journal of cancer.
[63] P. Wright,et al. Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods. , 1984, Biochemistry.
[64] L. Rutzky. The Biology of Human Colon Tumor Cells in Culture , 1985 .
[65] J. S. Cohen,et al. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. , 1987, The Journal of biological chemistry.
[66] P A Bottomley,et al. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? , 1989, Radiology.
[67] W. Wolberg,et al. Establishment and characterization of human colorectal cancer cell lines. , 1984, Cancer research.
[68] J A Frank,et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.
[69] G. Sommer,et al. In Vitro proton spectroscopy of normal and abnormal prostate , 1991, Magnetic resonance in medicine.
[70] C. Mountford,et al. Proton magnetic resonance spectroscopy and tumour detection. , 1987, Cancer surveys.
[71] C. Mountford,et al. Comparison of human polymorphonuclear leukocytes from peripheral blood and purulent exudates by high resolution 1H MRS , 1991, Magnetic resonance in medicine.
[72] M. Tattersall,et al. CLASSIFICATION OF HUMAN TUMOURS BY HIGH-RESOLUTION MAGNETIC RESONANCE SPECTROSCOPY , 1986, The Lancet.
[73] W. Bodmer,et al. Genetics and biochemistry of collagen binding-triggered glandular differentiation in a human colon carcinoma cell line. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[74] J S Taylor,et al. Chemical shift imaging of human brain: axial, sagittal, and coronal P-31 metabolite images. , 1990, Radiology.
[75] S. Kirkland,et al. Establishment and characterisation of six human colorectal adenocarcinoma cell lines. , 1986, British Journal of Cancer.
[76] H. Thielmann,et al. 31P NMR studies of cultured human tumor cells. Influence of ph on phospholipid metabolite levels and the detection of cytidine 5′‐diphosphate choline , 1990, NMR in biomedicine.
[77] P R Luyten,et al. Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1h nmr spectroscopic imaging , 1990, Magnetic resonance in medicine.
[78] C. Nicolau,et al. 1-H and 13-C nuclear magnetic resonance spectra of the lipids in normal and SV 40 virus-transformed hamster embryo fibroblast membranes. , 1975, Biochimica et biophysica acta.
[79] W. Mackinnon,et al. Further evidence that the narrow 1H magnetic resonance signals from malignant cells do not arise from intracellular lipid droplets , 1989, NMR in biomedicine.
[80] J. Voges,et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas , 1992, Annals of neurology.
[81] R. R. Ernst,et al. Two‐dimensional spectroscopy. Application to nuclear magnetic resonance , 1976 .
[82] W. Mackinnon,et al. NMR methods for characterizing the state of the surfaces of complex mammalian cells. , 1984, Journal of biochemical and biophysical methods.
[83] J. Frahm,et al. Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. , 1991, Journal of computer assisted tomography.
[84] C. Mountford,et al. Inhibition of metastatic potential by fucosidase: An NMR study identifies a cell surface metastasis marker , 1988, Journal of cellular biochemistry.
[85] O. Jardetzky,et al. 1H NMR spectroscopy: an approach to evaluation of diseased skin in vivo. , 1989, The Journal of investigative dermatology.
[86] J. Ruíz-Cabello,et al. Phospholipid metabolites as indicators of cancer cell function , 1992, NMR in biomedicine.
[87] J. Frahm,et al. On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro , 1992, NMR in biomedicine.
[88] D. Hoon,et al. A 6‐thioguanine‐resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic , 1982, International journal of cancer.
[89] S. Hakomori,et al. Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues. , 1986, Cancer research.
[90] W. Mackinnon,et al. Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. , 1992, Biochemistry.
[91] A. Leathem,et al. Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour , 1991, The Lancet.
[92] K. Behar,et al. Assignment of resonances in the 1H spectrum of rat brain by two‐dimensional shift correlated and j‐resolved NMR spectroscopy , 1991, Magnetic resonance in medicine.
[93] M. Legg. What role for the diagnostic pathologist? , 1981, The New England journal of medicine.
[94] A. Benabid,et al. In vivo 1H NMR spectroscopy of an intracerebral glioma in the rat , 1989, Magnetic resonance in medicine.
[95] J. Cohen,et al. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. , 1989, Cancer research.
[96] J. F. Cooper,et al. THE ROLE OF CITRIC ACID IN THE PHYSIOLOGY OF THE PROSTATE. 3. LACTATE/CITRATE RATIOS IN BENIGN AND MALIGNANT PROSTATIC HOMOGENATES AS AN INDEX OF PROSTATIC MALIGNANCY. , 1964, The Journal of urology.
[97] G. Nicolson. Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. , 1976, Biochimica et biophysica acta.
[98] M. Glick,et al. Malignant cell glycoproteins and glycolipids. , 1989, Critical reviews in oncology/hematology.
[99] W. Mackinnon,et al. Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells. , 1992, European journal of biochemistry.
[100] R C Newland,et al. Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system. , 1983, The Australian and New Zealand journal of surgery.
[101] E. Mazzaferri,et al. Thyroid cancer in thyroid nodules: finding a needle in the haystack. , 1992, The American journal of medicine.
[102] M. Tattersall,et al. Changing character of cervical cancer in young women. , 1989, BMJ.
[103] G. Sutherland,et al. High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.
[104] W. Negendank,et al. Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.